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Lack of GAS2L2 Causes PCD by Impairing Cilia
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Brian J. Mitchell,3 Corey M. Jania,4 Kirby L. Zeman,5 Troy D. Rogers,1 Laura E. Herring,6 Luc Refabért,7
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Michael R. Knowles,1 Maimoona A. Zariwala,9,10,* and Lawrence E. Ostrowski1,10,*
Primary ciliary dyskinesia (PCD) is a genetic disorder in which impaired ciliary function leads to chronic airway disease. Exome
sequencing of a PCD subject identified an apparent homozygous frameshift variant, c.887_890delTAAG (p.Val296Glyfs*13), in exon
5; this frameshift introduces a stop codon in amino acid 308 of the growth arrest-specific protein 2-like 2 (GAS2L2). Further genetic
screening of unrelated PCD subjects identified a second proband with a compound heterozygous variant carrying the identical frame-
shift variant and a large deletion (c.867_*343þ1207del; p.?) starting in exon 5. Both individuals had clinical features of PCD but normal
ciliary axoneme structure. In this research, using human nasal cells, mousemodels, andX.laevis embryos, we show that GAS2L2 is abun-
dant at the apical surface of ciliated cells, where it localizes with basal bodies, basal feet, rootlets, and actin filaments. Cultured GAS2L2-
deficient nasal epithelial cells from one of the affected individuals showed defects in ciliary orientation and had an asynchronous and
hyperkinetic (GAS2L2-deficient ¼ 19.8 Hz versus control ¼ 15.8 Hz) ciliary-beat pattern. These results were recapitulated in Gas2l2/
mouse tracheal epithelial cell (mTEC) cultures and in X. laevis embryos treated withGas2l2morpholinos. In mice, the absence of Gas2l2
caused neonatal death, and the conditional deletion of Gas2l2 impaired mucociliary clearance (MCC) and led to mucus accumulation.
These results show that a pathogenic variant in GAS2L2 causes a genetic defect in ciliary orientation and impairs MCC and results
in PCD.Introduction
Primary ciliary dyskinesia (PCD) is a rare genetic disorder
(MIM: 244400) in which dysfunction of motile cilia1
results in defective mucociliary clearance (MCC) and
chronic airway disease. The clinical features of PCD
include neonatal respiratory distress, bronchiectasis,
chronic rhinosinusitis, low nasal nitric oxide (nNO) pro-
duction, male infertility, and a spectrum of laterality de-
fects.1,2 Genetic variants in>40 genes have been identified
in individuals with PCD,3–12 and ultrastructural cilia de-
fects are observed in 70% of the cases;3 however, in
many other cases of PCD, the genetic lesions and ciliary
defect are still unknown.
The coordinated ciliary beat, with a specific frequency
and waveform, directs fluid and foreign materials toward
the mouth to be swallowed or expectorated.13 This coordi-
nation results from proper orientation and stabilization of
cilia along the tissue axis.14,15 Stabilization of basal bodies
at the surface of ciliated cells provides the foundation for
ciliary axoneme extension and the directionality of the
ciliary beat.16 The direction of the ciliary beat is evidenced
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la RechercheMédicale, Childhood Genetic Disorders, Département de Génétiq
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with disrupted rootlets18 or basal feet19 suggest that the
stabilization of basal bodies is essential for long-termmain-
tenance of ciliary function. In PCD, the ciliary beat and
waveform vary from absent to a range of uncoordinated
motions,20,21 impairing MCC and leading to the chronic
airway disease that characterizes PCD.22,23
We identified a PCD-causing apparent homozygous
variant and a compound heterozygous variant in the
growth-arrest-specific 2-like 2 (GAS2L2; [MIM: 611398],
[GenBank: NM_139285.3, 17q12]) in two individuals
with symptoms of PCD but with normal axoneme struc-
ture. GAS2L2 is a member of the GAS2 family, which in-
cludes GAS2, GAS2L1, GAS2L2, and GAS2L3.24,25 The
GAS2 family mediates crosstalk between actin filaments
and microtubules (MT). They all contain a calponin ho-
mology (CH) domain (a putative actin binding site) and
a GAS2-related (GAR) domain (a putative MT binding
domain), but only the GAS2-like proteins contain a larger
unstructured C terminus that contains the conserved
microtubule-tip localization sequences Ser/Thr-Xaa-Ile/
Leu-Pro (or SxIP motifs) necessary for interaction with
microtubule plus-end-binding (EB) proteins.25,26 TheCarolina, Chapel Hill, NC 27599, USA; 2Biology Department, University of
lar Biology, Feinberg School of Medicine, Northwestern University, Chicago,
Care Medicine, University of North Carolina, Chapel Hill, NC 27599, USA;
of North Carolina, Chapel Hill, NC 27599, USA; 6Department of Pharma-
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GAS2 [MIM: 602835] is expressed inmany human tissues27
and is involved in the regulation of microfilament dy-
namics during both the cell cycle and apoptosis.28,29 The
overexpression of GAS2 is a hallmark in myeloid leuke-
mia,30 and its absence has been related to infertility due
to follicle growth impairment in mice.31 GAS2L1 [MIM:
602128] is also expressed in multiple human tissues.24 It
localizes to the proximal end of mature centrioles and par-
ticipates in centriole dynamics and centrosome disjunc-
tion,32 inhibits the growth of red blood cells downstream
of thyroid receptor signaling,33 and is downregulated in
myeloid leukemia.34 GAS2L3 [MIM: 617224] is expressed
inmany cell types.35 It is essential for brainmorphogenesis
and development36 and might play a role in tumorigen-
esis.37 GAS2L2 has six exons, encodes a 97 kDa protein,
and is the least characterized member of the family. Previ-
ous studies showed that GAS2L2 localized with both actin
stress fibers and microtubules and thereby contributed to
different levels of actin-microtubule co-alignment.25 A
separate study showed that the transfection of GAS2L2
into HEK293 cells stabilized the interaction of the A2A
adenosine receptor with the Gsa subunit, increasing the
cellular cAMP content.38 However, little is known about
the localization and function of GAS2L2 in native tissues.
We sought to determine the expression and localization of
GAS2L2 specifically in airway cells, and its role in PCD
development. In normal airway ciliated cells, GAS2L2 lo-
calizes throughout the cytoplasm but is abundant near
basal bodies. In human and mouse airway cell cultures,
the absence of GAS2L2 impaired ciliary orientation, and
the ciliary beat was hyperactive and uncoordinated. Simi-
larly, in X. laevis the absence of Gas2l2 disrupted cilia rota-
tional polarity. Knockout of Gas2l2 in mice resulted in
neonatal death. Adult Gas2l2-conditional-KO mice devel-
oped a PCD phenotype with impaired nasal MCC. These
results demonstrate that defective ciliary orientation, re-
sulting from a genetic variant in GAS2L2, causes PCD.Material and Methods
Subjects
Individuals included in the study had a clinical diagnosis of PCD
confirmed by standard clinical diagnostic criteria. For studies of
affected individuals and their families, all individuals gave their
signed and informed consent. All protocols involving human
studies were approved by the University of North Carolina Medi-
cal School Institutional Review Board and the Ethics Review Board
of the Comité de Protection des Personnes CPP Ile-de-France III
(France) (approvals no. CPP07729 and CPP02748).Genetic Analysis
Identification of GAS2L2 variants was performed either by whole-
exome sequencing as previously described39 or by parallel
sequencing with a custom targeted-capture panel encompassing
38 genes implicated in PCD (Table S1) and 250 candidate genes
(SeqCap EZ Choice, Roche Diagnostics; details available on
request). Copy-number-variation analysis was performed with adepth-ratio comparison between the individuals sequenced in
the same run. Performing Sanger sequencing (Life Technologies)
validated the genetic GAS2L2 variants found in the affected indi-
viduals. Segregation analysis was performed on the available
DNA from family members (UNC-362). The primers used are listed
in Table S2. More than 455 unrelated individuals suspected of hav-
ing PCD were screened for biallelic genetic variants in GAS2L2 by
various methodologies, including whole-exome sequencing,
panel testing, and Sanger sequencing.Airway Epithelial Cell Cultures
Human bronchial epithelial (HBE) cells were obtained from male
and female, non-smoking donors lacking respiratory pathologies.
The HBE cells were provided by the Cystic Fibrosis Center Tissue
Procurement and Cell Culture Core under protocols approved by
the University of North Carolina (UNC) Medical School Institu-
tional Review Board. HBE cells were cultured at the air/liquid inter-
phase (ALI) as previously described.40
Human nasal epithelial (HNE) cells from proband PCD-1367
and controls were obtained as described.41 The nasal cells were
expanded as conditionally reprogrammed cells (CRCs).42 In brief,
irradiated 3T3J2 fibroblasts were seeded on collagen-coated culture
dishes 12 hr before coculture with HNE cells in CRCmedia supple-
mented with 5 mM of the Rho-associated kinase (ROCK) inhibitor
(Y-27632, Sigma SCM075). To induce cell differentiation, we
seeded cells in collagen-coated Millicell inserts (Millipore) and
cultured at the air-liquid interface.
Mouse trachea epithelial cells (mTECs) were isolated according
to established protocols.43 Tracheas were dissected from adult
mice or 18.5 days post-coito (dpc) embryos. The cells were
expanded and cultured as described above.Reverse-Transcription Polymerase Chain Reaction
Semiquantitative reverse-transcription polymerase chain reaction
(RT-PCR) for detection of GAS2L2was performed via standard pro-
tocols. In brief, total RNA from human tissues was obtained from
Takara Bio (Takara Bio). Total RNA from wild-type mouse tissues
and from airway epithelial cell cultures (human and mouse)
were isolated with an RNeasy kit (QIAGEN) according to the
manufacturer’s protocols. First-strand cDNA was synthesized
with SuperScript II Reverse Transcriptase (Thermo Fisher cat.#
18064014). PCRwas performedwith PrimeSTARHSDNA Polymer-
ase (Takara Bio) according to the manufacturer’s protocols. For the
normalization of RT-PCR analysis of human tissues, PPIA (cyclophi-
lin A) was used as a reference44 and DNAI1 as a control of ciliogen-
esis progression. RT-PCR analysis of mouse tissues was normalized
with TATA box protein (Tbp) and b-actin (Actb).45 The primers used
are listed in Table S3.Immunofluorescence and Co-localization Analysis
Immunofluorescence was performed as described previously.46 For
whole-mount staining, ALI cultures were washed with PBS and
fixed with 4% paraformaldehyde for 20 min at room temperature,
permeabilized with 0.2% Triton X-100 in Tris-buffered saline for
30min, and then incubated for 1 hr at room temperature in block-
ing solution (1% BSA, 1% fish gelatin, 0.1% Triton X-100, and 5%
fetal bovine serum). After primary antibody incubation, antibody
binding was detected with secondary antibodies conjugated
with Alexa Fluor-488, Alexa Fluor-647 (Life Technologies),
indocarbocyanine- (CY3), or Rhodamine Red-X (RRX) (Jackson
ImmunoResearch Laboratories). Actin filaments were stained
with phalloidin conjugated with Alexa Fluor 488 (Life Technolo-
gies A12379). For DNA staining, Hoechst 33342 trihydrochloride,
trihydrate-FluoroPure (Life Technologies) was used. No detectable
staining was observed for isotype-matched control antibodies.
Membranes were mounted on slides with ProLong Diamond anti-
fade mountant (Thermo Fisher). The antibodies used are listed in
Table S4. Whole-mount ALI cultures were imaged with a Leica
SP8 inverted confocal or a Nikon N-SIM microscope. Single cells
were imaged with a Nikon N-SIM microscopy system. Images
were processed and analyzed with FIJI.47 For co-localization anal-
ysis, single cells were embedded in 100 mM b-mercaptoethyl-
amine (Sigma) for ground-state depletion (GSD) super-resolution
microscopy (Leica). So that Pearson coefficients (r: values between
1 to 1; where 1 ¼ inverse association and 1 ¼ full association)
and Manders coefficients for magenta (M1) and green (M2) chan-
nels (M1 and M2; values vary from 0–1, where 0 ¼ no overlapping
and 1 ¼ 100% co-localization)48 could be obtained, images were
analyzed with the Coloc2 plugin of ImageJ49.
Immunoblots and Targeted Proteomics Analysis
Human nasal epithelial cells were lysed in RIPA buffer (Thermo-
fisher) supplemented with protease inhibitor cocktail (Sigma). Pro-
tein concentration was determined via the BCA method (Pierce
BCA kit, ThermoFisher Scientific). The samples (20 mg) were elec-
trophoresed on NuPage 4–12% Bis-Tris gels in MES-SDS running
buffer (ThermoFisher Scientific) and transferred to 0.45 mm
nitro-cellulose membrane for immunoblotting. Targeted prote-
omics is described in the Supplemental Data. The antibodies
used are listed in Table S4.
Analysis of Ciliary Function
Ciliary beat frequency was measured as previously described.50 In
brief, three to four cultures were individually visualized with a
Nikon Eclipse TE2000 inverted microscope with phase optics
and a 203 objective (NA¼ 0.45). The temperature wasmaintained
at 37C via a Tokai HITcontroller (model INU-TIZ-F1) and amicro-
scope stage-heater block. High-speed videos (60 frames/s) were
recorded with a Basler acA1300-200um camera controlled by
SAVA software (Ammons Engineering) and were analyzed via
SAVA whole-field analysis. For evaluation of the waveform and
beat direction, high-resolution videos of ciliated cells were re-
corded at 200 fps with a 603 Plan-Apo oil objective lens (NA ¼
1.4), DIC optics, and ambient temperature. Analysis of videos
was conducted by investigators blinded to the cells’ genotype.
Videos were replayed in slow motion (1/7 of the true speed).
For waveform analysis, three cilia were traced manually at the
end recovery and end effective positions in four ciliated cells
from each genotype. To evaluate the direction of the ciliary beat,
wemanually traced the tip positions of four to five individual cilia,
and the orientation of the ciliary beat was represented in a two-
dimensional plot.
Transmission Electron Microscopy and Scoring of Ciliary
Orientation
Fixed cultures were sectioned (1 mm) and stained.51 From three
biological replicates, 10 to 15 images of individual cells were
taken with a Zeiss 900 TEM at 10,0003. So that ciliary orientation
could be scored, the angle (0–360) between the center of the
basal body to the tip of the basal foot was determined with
ImageJ. The length of the mean vector (r)52 and the average of
the length of the mean vector (R) for each genotype were calcu-lated. The mean vector lengths were plotted with Oriana 4. The
R values were plotted with GraphPad Prism 7.1 and compared
via a Student’s t test.
Transgenic Gas2l2 Mice
All protocols were approved by the University of North Carolina at
Chapel Hill (UNC) Institutional Animal Care and Use Committee
(IACUC). A knockout-first Gas2l2tm1a(KOMP)Wts/i/þ (Gas2l2þ/)
mouse in a C57BL/6N; C57BL/6N-Atm1Brd/a background was ac-
quired from the Wellcome Trust Sanger Institute knockout mouse
project (KOMP).53 After several unsuccessful attempts at breeding,
the mouse was euthanized, and in vitro fertilization was used for
generation of the Gas2l2þ/ line in the same genetic background.
Gas2l2fl/fl mice were generated from a cross of Gas2l2þ/ mice to a
Rosa26::FLPe mouse (Jackson Laboratory stock no.: 003946) so
that the lacZ and neo cassettes were removed. The Gas2l2fl/fl
mice therefore contain loxP sites flanking exon 2 of Gas2l2.
Tamoxifen inducible Gas2l2 conditional-knockout (Gas2l2 condi-
tional-KO) mice were obtained by crossing Gas2l2fl/fl mice to
RosaCreER mice (Jackson Laboratory stock no.: 004847) or to
Foxj1CreERT2::GFP/þ mice (Jackson Laboratory stock no.: 027012).54
Treatment with tamoxifen activates Cre and causes the deletion
of exon 2. Primers used for genotyping are listed in Table S3.
Tamoxifen Treatment and CT-Scan Analysis
For all studies, Gas2l2fl/fl:Foxj1CreERT2::GFP/þ (Gas2l2fl/fl:Foxj1CreERT2)
and control animals were treated with tamoxifen55 (dissolved in
pure corn oil at 20 mg/mL; Sigma-Aldrich). Animals received
three intraperitoneal injections of tamoxifen (75 mg/kg body
weight) every other day so that the initial deletion of Gas2l2
would be induced, and thereafter they were maintained on a
tamoxifen-supplemented diet (Envigo TD.130860). In most ex-
periments, Gas2l2 conditional-KO animals were compared to
litter mate control mice of genotypes Gas2l2fl/fl or Gas2l2fl/þ:
Foxj1CreERT2. For evaluation of the development and progression
of the PCD phenotype, the nasal cavity of the mice was scanned
by micro-computed tomography (micro-CT) four times, starting
at the end of the last tamoxifen injection (baseline) and repeating
every 30 days. Micro-CT scans were analyzed with Mimics
Research 18.0, and the volume of the nasal air space (V) was
calculated. The change in nasal air space (DV) was calculated by
subtracting the baseline nasal air space (vbaseline) from the volume
measured at 90 days (V90).
Measurement of MCC
For measurement of MCC in the nasal cavity and in the anterior
nasopharynx, the clearance of radiolabeled 99mtechnetium colloid
particles56 or dry green-fluorescent beads,57 respectively, was
recorded. Analyses were performed using ImageJ48 and Mosaic
plugin.58
Histology of the Nasal Cavity
After measurement of MCC, the heads of the mice were fixed and
processed as previously described.59 Coronal sections of the nasal
cavity were stained with hematoxylin and eosin (H&E) and with
alcian blue and periodic acid Schiff (AB-PAS) stain so that mucus
accumulation could be visualized. For comparisons between geno-
types, the samples were screened for the presence ofmucus and for
degeneration of the epithelium. The presence of mucus was scored
from one to four as previously described.59 Images were taken with
an Olympus VS120 virtual slide scanner microscope.
Figure 1. GAS2L2 Pathogenic Variants in
Individuals with PCD
(A) Segregation analysis of GAS2L2 genetic
variants found in family UNC-362
(c.887_890delTAAG [p. Val296Glyfs*13])
and in familyDC-630 (c.887_890delTAAG;
867_*343þ1207del [p.Val296Glyfs*13;?]).
Filled symbols indicate PCD-affected indi-
viduals. In family UNC-362, individual 2-I
is a heterozygous carrier, individual 2-II
died at age 5 years as a result of a ruptured
appendicitis. Individual 2-III was a lifelong
smoker and died of lung cancer at
55 years. Individual 2-VI is proband
PCD-1367. Individual 2-VII was a term
neonate suspected to have had PCD as a
result of neonatal respiratory distress and
severe hypoxemia. She died at 2 weeks. In-
dividual 2-VIII is suspected to have had
PCD as a result of phenotypic features
including daily cough and bronchiectasis
at age 10 yearswith subsequent lobectomy.
He passed away from lymphoma at
50þ years.
(B) A transmission electron micrograph of
axonemal cross sections of nasal epithe-
lium frombothprobands shows the central
pair (brown arrowhead) surrounded by
nine microtubule doublets. Outer dynein arms (blue arrowhead) and inner dynein arms (black arrowhead) project from each doublet
normally.
(C) Schematic representation of the GAS2L2 variants found in the PCD-affected individuals. The top panel shows normal exon-intron
structure, themiddle panel shows the small four-nucleotide deletion (c.887_890del) that introduces an early stop codon, and the bottom
panel shows the large deletion (c.867_*343þ1207del) that is also located in exon 5. Red boxes indicate the coding exons, patterned boxes
indicate out-of-frame sequence, and gray boxes indicate the 50 and 30 UTRs.
(D) Schematic representation of GAS2L2 structure. It contains a calponin homology (CH, blue) domain and a GAS2-related domain
(GAR, green), which might mediate binding to the actin cytoskeleton and MT, respectively. Conserved SxIP motifs for interaction
with EB proteins are indicated in orange. The location of the mutations is indicated by the red arrows. The small deletion
induces a frameshift variant that introduces a stop codon in amino acid 308. The large deletion disrupts the protein after the
GAR domain.Xenopus laevis Embryo Manipulation and Analysis
Xenopus embryos were obtained by in vitro fertilization according
to standard procedures.60 All protocols were approved by the
UNC IACUC committee. The X. laevis genome contains two
largely identical Gas2l2 copies that have different start codons.
Two separate morpholinos (Table S3) targeting the start codon
of each isoform were designed on the basis of the sequences
from the NIBB database and obtained from Gene Tools. To
deplete both isoforms simultaneously, Gas2l2 morpholinos
(Gas2l2-MO) were injected together at 20-60 ng/blastomere into
the two ventral cells at the four-cell stage so the ciliated epidermis
was targeted. Coinjection of Centrin 4-RFP mRNA (Unigene ID:
Xl.50473) and Clamp-GFP mRNA (Unigene ID: Xl.26316) labeled
basal bodies and ciliary rootlets, respectively. For immunostain-
ing and confocal imaging analysis, X. laevis embryos at stage 28
were processed as previously described.61 Antibodies anti-g-
tubulin and anti-Gas2l2 were the same as described above. All im-
aging of X. laevis ciliated cells was performed on a Nikon A1R
laser scanning confocal microscope with a 603 oil plan-Apo
objective lens (1.4 NA). Cilia orientation was scored as previously
described.62 In brief, individual rootlet orientation was scored
manually by measurement of the angle of orientation of the root-
lets relative to the anterior–posterior axis of the embryo. Mean
vector-length calculations and graphical representation of cilia
orientation via circular plots were performed with Oriana 4.02
software.Statistical Analysis
Data are expressed as the mean5 standard deviation (SD) of n ex-
periments. In these studies, we used the following statistical
methods: two-tailed Student’s t test with Welch’s correction,
Paired t test, one-way ANOVA with Tukey’s multiple comparisons,
chi-square test, and Pearson’s correlation test. Figure legends
specify the statistical method used for each experiment. P values
less than 0.05 were considered significant.Results
Discovery of Genetic Variants in GAS2L2
Although genetic variants in more than 40 genes have
been identified as causes of PCD,1,4–8 in many cases of
PCD the genetic lesion has not yet been identified. To un-
cover additional variants that cause PCD, we performed
whole-exome sequencing of a subject with clinical
features consistent with PCD (Table S5). We identified
an apparent homozygous frameshift variant, c.887_
890delTAAG (p.Val296Glyfs*13) (dbSNP: rs587633197)
in exon 5 of GAS2L2 (GenBank: NM_139285.3) (Figures
1A and S1A). Proband PCD-1367 from family UNC-362
(2-VI) was diagnosed at the age of 56 years. DNA from
the parents was not available; however, subject 2-I is a
Figure 2. Expression and Localization of GAS2L2
(A) Total RNA from different human tissues was used for determining the expression of GAS2L2. PPIA was used as a reference.
(B) Expression of GAS2L2 in normal HBE cells. Total RNA was extracted at the different indicated days of ALI culture. The expression of
GAS2L2 correlated with the expression of DNAI1, a ciliated-cell-specific gene. PPIA was used as a reference.
(C) Whole-mount immunofluorescence. HBE cultures were fixed at different days during the differentiation of airway cells and stained
for actin filaments (gray) and GAS2L2 (green), and nuclei (magenta) were labeled with Hoechst 33342. GAS2L2 was not detected in un-
differentiated cells (days four through eight). It was observed in the cytoplasm of HBE cells (day 16), and it was strongly present in fully
differentiated cultures (day 32).
(D) Isolated cell immunofluorescence. Cells were stained for GAS2L2 in green and in magenta: (1) the ciliary axoneme marker Acety-
lated-atubulin; (2) basal-body marker g-tubulin; (3) actin filaments and ERICH3 (blue), a ciliary axoneme marker; and (4) the rootlet
marker rootletin. Nuclei (yellow) were labeled with Hoechst 33342.
(E) Whole-mount culture immunofluorescence. GAS2L2 is closely associated with centrin-2 (top panel) and centriolin (middle panel).
GAS2L2 strongly localizes with EB3 (bottom panel).
(legend continued on next page)
heterozygous carrier, and the family history suggested
that two other siblings were affected by PCD
(Figure 1A); these included a sister who had neonatal res-
piratory distress and severe hypoxemia and died at 2 weeks
and a brother who had a daily cough and bronchiectasis
and underwent a lobectomy. During the course of this
research, a second individual with a compound heterozy-
gote genetic variant in GAS2L2 was identified (Figure 1A).
Proband DCP-1040 (2-I) from family DC-630 carries the
same c.887_890delTAAG (p. Val296Glyfs*13) frameshift
variant and a large deletion (c.867_*343þ1207del p.?)
(LOVD: 0000439768] starting in exon 5 (Figure S1B).
DNA from the parents was not available, and they had
no report of upper or lower chronic respiratory disease.
The location of the two deletions that proband DCP-
1040 carries indicates that she is an obligatory compound
heterozygote. Indeed, within GAS2L2 exon 5, the 50 break-
point of the large deletion c.867_*343þ1207del (with a 30
breakpoint in the adjacent gene RASL10B and, therefore,
encompassing GAS2L2 exon 6) is upstream of the
small four-nucleotide deletion c.887_890del, also located
in exon 5. Next-generation sequencing (NGS) data
(Figure S2A) highlights the absence of a normal allele
for exon 5 because reads either include c.867_*
343þ1207del or c.887_890del. Additionally, copy-number
analysis based on NGS read depth (Figure S2B) confirmed
the heterozygous deletion of exon 6 and the partial
heterozygous deletion of exon 5. Both individuals have
similar clinical phenotypes, including bronchiectasis,
otitis media, and rhinosinusitis (Table S5). However, the
ultrastructure of the ciliary axoneme was normal
(Figure 1B), and one of the individuals had normal levels
of nasal NO (nNO ¼ 342.6 nL/min, cutoff 77 nL/min)63
(Table S5). The GAS2L2 genetic variants that we identified
in the PCD-affected families (Figure 1C) are both pre-
dicted to result in the absence of protein production
as a result of immature full-length transcripts and/or
nonsense-mediated mRNA decay. GAS2L2 possesses a
GAS2-related (GAR) domain for interacting with microtu-
bules and a calponin homology (CH) domain for interact-
ing with actin filaments.24,25 Interestingly, GAS2L2 has
a long C terminus with five putative SxIP sites for
interaction with microtubule-end-binding (EB) proteins
(Figure 1D). The frameshift variant induces a stop codon
in amino acid 308, after the microtubule-binding domain
(Figure 1D). The large deletion (3,931 nucleotides) might
disrupt the putative protein after the GAR domain
(Figure 1D). Because of these findings, we sought to deter-
mine the expression and localization of GAS2L2 specif-
ically in airway cells and its possible role in PCD
development.(F) Single-molecule detection using GSD super-resolution microsco
(green) and in magenta: (1) g-tubulin, (2) EB1, (3) centrin-2, (4) acti
scanned in GSDmode. Pearson coefficients for each analyzed cell are
for GAS2L2 (M1) and the partner protein (M2) are indicated.GAS2L2 Is a Ciliated-Cell-Specific Protein
In control human tissues, GAS2L2 transcript was abun-
dant in tissues with motile cilia; including brain, lung,
testis, and fallopian tube. GAS2L2 expression was also de-
tected in kidney tissue, and less abundantly in stomach
and colon tissue (Figure 2A). To determine the expression
and localization of GAS2L2 during HBE cell differentia-
tion, we used RT-PCR and immunofluorescence, respec-
tively (Figures 2B and 2C). The expression of GAS2L2
was not detected in undifferentiated cells. By day 12 of
ALI culture (Figure 2B), we observed a weak GAS2L2 signal
correlating with the expression of DNAI1 [MIM: 604366].
At later time points, GAS2L2 was strongly expressed in a
similar pattern to that of DNAI1 (Figure 2B), and the pro-
tein was abundant in the cytoplasm of HBE cells
(Figure 2C). In single-cell immunostaining, GAS2L2
strongly localized at the base of the cilia (Figure 2D-1),
close to g-tubulin (a basal body marker, Figure 2D-2).
Also, GAS2L2 was detected in the cytoplasm of ciliated
cells, and it partially localized with actin filaments
(Figure 2D-3) and rootletin (a rootlet marker; Figure 2D-
4). In whole-mount cultures (Figure 2E), we confirmed
the cytoplasmic localization of GAS2L2 with centrin-2
(Figure 2E, top panel) and centriolin (basal feet marker,
Figure 2E, middle panel) at the base of the cilia. GAS2L2
also localized with EB3 (Figure 2E, bottom panel), an
interaction previously described.25 GAS2L2 was not de-
tected in secretory cells labeled with CC10 and MUC5B
(Figures S3A and S3B). Co-localization analysis showed
that GAS2L2 co-localizes with g-tubulin (Pearson’s coeffi-
cient, r ¼ 0.62 5 0.18; Manders coefficients, M1 ¼ 0.6, M2
¼ 0.7; Figure 2F-1) and partially co-localizes with EB1 (r ¼
0.21 5 0.06; M1 ¼ 0.2, M2 ¼ 0.3, Figure 2F-2), centrin-2 (r
¼ 0.23 5 0.08; M1 ¼ 0.3, M2 ¼ 0.3; Figure 2F-3), and actin
(r ¼ 0.28 5 0.14; M1 ¼ 0.3, M2 ¼ 0.4; Figure 2F-4) but not
with rootletin (r ¼ 0.18 5 0.02; M1 ¼ 0.2 and M2 ¼ 0.1;
Figure 2F-5). These results suggest that GAS2L2 interacts
closely with proteins present at the basal body.
The Loss of GAS2L2 Disrupts Cilia Beat Frequency and
Orientation
To investigate the functional role of GAS2L2 in ciliated
cells, we cultured HNE cells from the proband PCD-1367
(GAS2L2-deficient) and control cells and expanded them
as CRCs.42 (Figure 3A). The screening of GAS2L2-deficient
cells by immunoblot and immunofluorescence showed
complete absence of GAS2L2 (Figures 3B and 3C). Also, a
truncated form of the protein was not detected by targeted
proteomics (Figure S4A and Table S6; see also Supple-
mental Methods). In PCD-1367 cells, the transcript of
GAS2L2 was reduced (Figure S4B), possibly as a result ofpy showing representative images of cells stained with GAS2L2
n, and (5) rootletin. The boxed area in the bright-field image was
represented in the graph (nR 4). The average Manders coefficient
Figure 3. The Absence of GAS2L2 Causes a Defective Ciliary Beat
(A) Nasal epithelial cells from individual PCD-1367 (family UNC-362, 2-VI) and a control were dissociated into single cells. The HNE cells
were conditionally reprogramed and expanded by co-culture with irradiated 3T3J2 fibroblasts for one to two passages in the presence of
Y-27632, a selective inhibitor of Rho-associated protein kinase (ROCK). After expansion, we cultured the HNE cells at the ALI to conduct
multiple assays.
(B and C) The absence of GAS2L2 in PCD-1367 was confirmed by immunoblot and immunofluorescence.
(D) The CBF in GAS2L2-deficient cells was hyperkinetic in comparison to controls (n ¼ 6; data are represented as the mean þ SD;
Student’s t test, ***p ¼ 0.0002).
(E) High-resolution videos of ciliated cells were observed and showed a normal waveform pattern of ciliary beat in control and GAS2L2-
deficient cells. The images represent a time point of the cilia seen in profile at end recovery (left panels) and end effective positions (right
panels). For each position, a panel showing the manual tracing of the cilia (highlighted in red) is shown. (n ¼ 4; the scale bar represents
4 mm).
(legend continued on next page)
nonsense-mediated decay of the mRNA. The ciliary beat
frequency (CBF) was significantly faster in GAS2L2-defi-
cient (19.8 5 0.2 Hz) cells than in control cells (15.8 5
0.1 Hz; p¼ 0.0002; Figure 3D). Although the waveform ap-
peared normal in ciliated cells from proband PCD-1367
(Figure 3E, additional traces are shown in Figure S5 and
Videos S1 and S2), the direction of the ciliary beat appeared
to be randomized (Figure 3F, top panel; also Video S3) in
comparison to control cells (Figure 3F, bottom panel; also
Video S4). To further analyze the coordination of the
ciliary beat, we measured the orientation of the basal feet
in individual ciliated cells. In cell culture, the direction of
the ciliary beat varies between cells, but it is well coordi-
nated within individual cells; however, in GAS2L2-defi-
cient cells the alignment of the basal feet was significantly
randomized (Figure 3G). The length of the mean vector (r)
was shorter in the GAS2L2-deficient cells (r ¼ 0.05) than in
control cells (r ¼ 0.469). This was further reflected by a low
average length of the mean vector (R) for GAS2L2-deficient
cells compared to control cells (0.41 þ 0.034 versus 0.65 þ
0.065; p < 0.001, Figure 3H). These results demonstrate
that the absence of GAS2L2 in human airway ciliated cells
causes a ciliary orientation defect and affects the perfor-
mance of the cilia.
Deletion of Gas2l2 Causes Neonatal Lethality in a Mouse
Model
To analyze the function of GAS2L2 in vivo, we used a
Gas2l2-knockout-first mouse (Gas2l2tm1a(KOMP)Wtsi or
Gas2l2þ/) (Figure 4A). More than 90% of the Gas2l2þ/
mice survived, and they had no signs of a PCD phenotype.
Because in mouse, as in humans, the localization of Gas2l2
expression is largely unknown, we took advantage of the
presence of the lacZ reporter in Gas2l2þ/ mice and de-
tected b-galactosidase activity in tissues with motile cilia;
such tissues included those of the brain, nasal septum, tra-
chea, lungs, and testis (Figure S6A). RT-PCR corroborated
these results (Figure S6B). Matings between heterozygous
Gas2l2þ/ mice resulted in a high incidence of neonatal
death (29%). Of the 265 mice that survived, only two
wereGas2l2/ (Figure 4B). These mice showed signs of hy-
drocephalus at 14 and 21 days of age. Histology of the head
(Figure 4C) showed mucus accumulation in multiple si-
nuses and remodeling of the nasal cavity, a typical pheno-
type of murine PCD models (e.g., Dnaic1/ mice).59 To
evaluate inheritance ratios, we genotyped 18.5 dpc em-
bryos; 13% (6/48) were homozygous (x2obs ¼ 6.00, with
2 degrees of freedom; p ¼ 0.05; Figure S6C), consistent
withMendelian distribution. Of the sixGas2l2/ embryos(F) Direction of ciliary beat. Four to five cilia were tracked manually in
end recovery phase. The direction of the ciliary beat was plotted on
(G) Representative electron micrograph showing the analysis of align
GAS2L2-deficient cells (n¼ 22). The arrows in eachmicrograph are po
2 mm).
(H) The length of the vector (0< R< 1) for each cell is represented in t
in GAS2L2-deficient nasal ciliated cells than in control cells (data arecollected, three showed dextrocardia (Figure 4D), suggest-
ing that Gas2l2 is expressed in ciliated cells at the node
and might play a role in situs determination.Deletion of Gas2l2 in mTEC Cultures and in X. laevis
Embryos Recapitulates the Ciliary Phenotype Observed
in Humans
To further investigate the role of GAS2L2 in ciliary func-
tion, we used two vertebrate models: the knockout mouse
and X. laevis embryos. In wild-type cells from both species,
GAS2L2 localized at the base of the cilia, near the basal
bodies (Figures 5A and 6A). To investigate the effects of
Gas2l2 deletion, we cultured mTEC isolated from embry-
onic tracheas. We pooled tracheas of the same genotype,
digested them to obtain a single cell suspension, expanded
them as CRC cells, and then cultured them at an ALI until
they were differentiated. The absence of Gas2l2 was
confirmed by RT-PCR (Figure S7A). The CBF of Gas2l2/
mTEC was hyperkinetic (24.71 5 1.28 Hz) in comparison
to controls (Gas2l2þ/þ ¼ 18.77 5 0.94 Hz, Figure 5B and
Gas2l2þ/ ¼ 20.57 5 0.80 Hz; data not shown). We
observed a lack of alignment of the basal feet within indi-
vidualGas2l2/ cells (r¼ 0.40; R¼ 0.465 0.08) compared
to Gas2l2þ/þ cells (r ¼ 0.60; R ¼ 0.71 5 0.06, Figures 5C
and 5D) and Gas2l2þ/ cells (r ¼ 0.51; R ¼ 0.76 5 0.036;
data not shown). The distribution and spacing of the basal
bodies were similar between the Gas2l2/ and the wild-
type cells (Figure 5E).
The multiciliated skin cells of X. laevis embryos generate
a robust flow oriented from anterior to posterior. X. laevis
expresses two isoforms of Gas2l2; therefore, morpholinos
(MO) targeting both isoforms were injected into embryos
(Gas2l2-MO embryos). To visualize and score the orienta-
tion of individual cilia, the embryos were co-injected
with Centrin 4-RFP (rootlet marker) and Clamp-GFP
(basal-body marker) mRNA.61 The targeting of Gas2l2 re-
sulted inmosaic embryos (Figure S7B). The decreased levels
of Gas2l2 affected the number and distribution of basal
bodies on the surface of ciliated cells (Figures 6B and 6C).
The ciliary orientation was significantly reduced in
Gas2l2-MO embryos (r ¼ 0.67, CSD ¼ 51.2) compared to
controls (r ¼ 0.98, CSD ¼ 11.5; Figures 6B0 and 6C0).
This phenotype was rescued when human GAS2L2
mRNA (GAS2L2-R) was co-injected (r ¼ 0.91, CSD ¼
25.6; p < 0.0001). In addition, the average of the length
of the vectors from ciliated cells in Gas2l2-MO embryos
was significantly shorter than in control-MO and
GAS2L2-R embryos (Figure 6D).three individual cells. The black dot represents the position at the
an X-Y graph (the scale bar represents 2 mm).
ment of the basal body and basal foot in control cells (n ¼ 14) and
inting in the direction of the basal foot tip (the scale bar represents
he graph. The average length of the vector was significantly shorter
expressed as the mean þ SD; Student’s t test, ***p ¼ 0.0004).
Figure 4. Deletion of Gas2l2 In Vivo
Causes a Lethal Trait in Mice
(A) The knockout-first allele contains an
IRES:lacZ and a promoter-driven neo
cassette inserted into an intron of Gas2l2,
disrupting Gas2l2 expression.53 See Mate-
rial and Methods for details.
(B) From the Gas2l2þ/ 3 Gas2l2þ/
crosses, 265 mice survived; of these, two
were homozygous.
(C) Histological head sections of the two
Gas2l2/ and control mice at P14 and
P21. The heads were stained with AB-PAS,
which revealed severe mucus accumula-
tion in the sinuses of both Gas2l2/
mice (arrows). Abbreviations are as follows:
ET, ethmoturbinates; MS, maxillary sinus;
and NC, nasal cavity.
(D) Situs ambiguous was observed in three
out of six Gas2l2/ mouse embryos
dissected at 18.5 dpc. Dextrocardia was
clearly observed as the apex of the heart
(yellow arrow head) was oriented to the
right side of the body axis. Abbreviations
are as follows: RV, right ventricle; LV, left
ventricle; RA, right atrium; LA, left atrium;
Ao, Aorta; PT, pulmonary trunk; and OFT,
out-flow tract.Gas2l2 Conditional-KO Mouse Develops a PCD-like
Phenotype
To understand the role of GAS2L2 in PCD development, we
generated conditional-knockout (KO)mice (Figure 7A). The
Gas2l2fl/fl mice were first crossed to a ROSA26CreER mouse.
However, we detected by PCR a high incidence of sponta-
neous deletion of Gas2l2 (Figure S8A), and most of the
Gas2l2fl/fl:RosaCreER/þ mice died soon after birth. Tracheal
cells from surviving Gas2l2fl/fl:RosaCreER/þ and control
micewere expanded as CRCs and cultured at ALI. To induce
the complete deletion of Gas2l2, we treated the cultures
with tamoxifen (TMX; 1 mM)64 and confirmed the deletion
by RT-PCR (Figure S8B). The TMX-treated cultures (Figures
S8C and S8D) recapitulated the phenotypes observed in
GAS2L2-deficient HNE cells (Figure 3) and in mTEC cul-
tures from Gas2l2/ embryonic trachea (Figure 5).
We generated viable conditional-KO (Gas2l2fl/fl:
FoxJ1CreERT2) mice by crossing Gas2l2fl/fl mice to
Foxj1CreERT2::GFP/þ (knockin/knockout) mice expressing
Cre recombinase exclusively in cells with motile cilia.
The offspring from this cross had a high rate of neonatal
survival (98%), but we observed isolated cases of hydro-
cephalus (3%). Conditional-KO and control animals
were injected with TMX and maintained on a TMX- sup-
plemented diet. In a cohort of 41 mice included in these
experiments, the TMX-supplemented diet did not affect
the weight or survival of the mice. However, this treatment
did not completely abolish Gas2l2 expression in the tra-
chea (Figures 7B and S9).
Mouse models of PCD develop a phenotype character-
ized by chronic rhinosinusitis and accumulation of mucusin the nasal cavity.59 To follow the development of rhino-
sinusitis and mucus accumulation, the nasal cavities of the
mice were imaged using micro-CT. The mice were imaged
four times at four-week intervals, starting after the third
TMX injection (baseline). The CT scans were compared
to histological sections (Figure 7C). Of the 21 Gas2l2fl/fl:
Foxj1CreERT2 mice treated with TMX, 80% developed
mucus plugging in multiple nasal cavities and increased
nasal air space due to remodeling of the nasal cavity. The
nasal air space increased over time and was significant at
two and three months after treatment (Figure 7D). These
results confirm that the deletion of Gas2l2 caused a PCD
phenotype in mice.
Impaired MCC in Gas2l2 conditional-KO mice
To directly determine the effect of the deletion ofGas2l2 on
MCC, we used a noninvasive method to monitor in real
time the nasal clearance of Gas2l2fl/fl:Foxj1CreERT2 and con-
trolmice.56 After the intranasal administration of the radio-
active tracer Technetium-99 (99mTc), radioactive particles
were observed at the tip of the nose at time 0 (Figure 8A,
left panel). These particles were then cleared toward
the oropharynx, where they accumulated over time
(Figure 8A, central and right panels). The average clearance
in Gas2l2-conditional-KOmice was significant in compari-
son to that of Dnaic1/ mice, which show no MCC
(Figure 8B). However, in the Gas2l2-conditional-KO mice
we observed that the impairment of clearance (with respect
to that in control mice) correlated with changes in nasal air
space (DV ¼ V90  Vbaseline, Figure 8C, Pearson’s r ¼
0.7672, p < 0.0001) and the presence of mucus in the
Figure 5. Absence of GAS2L2 in Mouse Tracheal Ciliated Cells Affects CBF and Ciliary Orientation
(A) Detection of GAS2L2 in tracheal ciliated cells from a wild-type mouse by immunofluorescence. Tracheal sections were stained for
GAS2L2 (green) and Acetylated-a tubulin (magenta). Nuclei (gray) were labeled with Hoechst 33342.
(B) The CBF in Gas2l2/ mTEC cells was hyperkinetic in comparison to control (n¼ 9; data are represented as the meanþ SD; Student’s
t test, **p ¼ 0.0033).
(C) Representative electron micrographs showing the analysis of alignment of the basal body and basal foot in cells from Gas2l2þ/þ
(n ¼ 8) and Gas2l2/ (n ¼ 8) cultures. The scale bar represents 2 mm.
(D) The length of the vector (0< R< 1) for each cell is represented in the graph. The average length of the vector was significantly shorter
in Gas2l2/ ciliated cells than in control cells (data are expressed as the mean þ SD; Student’s t test, **p ¼ 0.0232).
(E) Normal distribution of basal bodies in wild-type and Gas2l2/ mTEC cells.nose. Thosemice that had normal clearance had no change
in DVand nomucus accumulation (fivemice), or had DV<
5 mm3 and a mucus-accumulation score of 1 (seven mice).
The mice with impaired clearance (nine mice) had DV >
5mm3 and obvious mucus accumulation (score¼ 2). Addi-
tionally, we measured the clearance of fluorescent micro-
spheres in the nasopharynx at the end of the study. In
this technique, which avoids retention of particles in the
nasal turbinate, the fluorescent beads were delivered at
the ventral wall of the nasopharyngeal (NP) meatus. The
effective speed of MCC in Gas2l2fl/fl:Foxj1CreERT2 mice
(11.63 5 2.97 mm/sec; n ¼ 21) was significantly slower
than that in control mice (13.31 5 2.17 mm/sec, p ¼
0.0168, paired t test; n ¼ 20), and the directionality of the
flow was significantly affected in Gas2l2-conditional-KO
mice compared to controls (chi-square x2 ¼ 1.71; df ¼ 1,Figure 8D, Videos S5 and S6). The beads were transported
in various directions, usually at an angle, and the forward
movement was intermittent (Figure 8D and Video S6).
This phenotype was observed in the 16 mice that had
increased nasal air space and mucus accumulation in the
nose. These results show that GAS2L2 is necessary for effec-
tive MCC in the mouse upper airways.Discussion
We have identified two unrelated probands who have
clinical symptoms of PCD and harbor pathogenic vari-
ants in GAS2L2. Proband PCD-1367 carries an apparent
homozygous frameshift variant (c.887_890delTAAG
[p. Val296Glyfs*13]), and proband DCP-1040 harbors
Figure 6. Absence of Gas2l2 in X. laevis Affects Cilia Rotational Polarity
(A) Detection of Gas2l2 in a wild-type skin ciliated cell by immunofluorescence.
(B and C) Representative immunofluorescence images visualizing basal bodies (Clamp-GFP) and rootlet (Centrin 4-RFP) to score basal
body-rootlet alignment.
(B0 and C0) Alignment of the basal body and rootlet in control-MO (n ¼ 19, mean vector, black arrow, r ¼ 0.98, CSD ¼ 11.5) and
Gas2l2-MO (n ¼ 21, r ¼ 0.67, CSD ¼ 51.2).
(D) The vector length (R) of each analyzed cell is represented in the graph. The average length of the vector was significantly shorter
in Gas2l2-MO (R ¼ 0.5884 5 0.1259) cells than in controls (R ¼ 0.836 5 0.0847). The introduction of human GAS2L2 mRNA in
morpholino-treated embryos (GAS2L2-R) rescued the phenotype (n ¼ 23, R ¼ 0.7728 5 0.1322) (ANOVA, multiple comparison,
p < 0.0001).compound heterozygous variants (c.887_890delTAAG
[p.Val296Glyfs*13] and c.867_*343þ1207del p.?), consis-
tent with a likely recessive trait. Interestingly, more than
400 unrelated individuals with symptoms of PCD were
screened, but none harbored bi-allelic variants in
GAS2L2. The pathogenic variants that we describe are
rare in the public databases. For example, in gnomAD65
the c.887_890delTAAG variant had an allele frequency
of 4.9243 104 (130 of 276,682 alleles); none were homo-
zygous. Thus, on the basis of allele frequency, the chance
that this variant would appear in a homozygous state
is approximately one in 4.5 million individuals. The
GAS2L2 genetic variants were considered pathogenic
because (1) GAS2L2 showed coordinated expression with
multiple other genes known to be associated with human
PCD in UGET,66 (2) both variants are predicted to produce
a truncated protein or no protein, and (3) GAS2L2 is not
implicated in any other inherited disorder.
Both affected individuals had normal ciliary axonemal
ultrastructure by TEM. Several studies have provided exam-
ples of individuals who suffer from PCD but have normalultrastructure of the ciliary axoneme by TEM; for example,
such individuals might have genetic variants inDNAH1167
[MIM: 603339] or CCDC6568 [MIM: 611088]. Although in
these cases the ciliary axoneme appears normal, the vari-
ants result in a stiff and hyperkinetic ciliary beat.67,68 In
contrast, GAS2L2-deficient ciliated cells had a normal
waveform but a hyperkinetic ciliary beat. Importantly,
the orientation of basal bodies, and therefore the direction
of ciliary beating, was disrupted. Previously, the disorienta-
tion of cilia was described in several cases of PCD.69–71 In
all these cases, the cilia had normal axonemal ultrastruc-
ture and a normal ciliary beat frequency, but they had
impaired ciliary orientation and clearance. Because of
these reports, it was suggested that ciliary disorientation
could be a different variant of PCD. However, ciliary disori-
entation was also found in individuals with chronic
respiratory-tract inflammation, and it was reversed by
treatment with antibiotics.72 This suggested that ciliary
disorientation was a secondary effect of infection or
inflammation and was not the cause of PCD. Independent
of the causes leading to disorientation of the cilia, these
Figure 7. Partial Deletion of Gas2l2 in Mice Induces a PCD-like Phenotype
(A) Schematic representation of the generation of Gas2l2-conditional-KO mouse. See Material and Methods for details.
(B) Reduced expression of Gas2l2 was confirmed by RT-PCR with RNA extracted from trachea rings. Tbp was used as reference for
normalization.
(C) Representativemicro-CTscan and AB-PAS histology of animal heads after 90 days of treatment. Mucus accumulation in the turbinate
(arrow head) and increased volume of the sinuses (arrow) was observed in the conditional-KOmice but not in the control. Abbreviations
are as follows: ET, ethmoturbinates; MS, maxillary sinus; and NC, nasal cavity.
(D) Measurement of total nasal-cavity air space in all the animals (n ¼ 41) included in these experiments. A significant increase in nasal
air space in the conditional-KO mice (red line) compared to controls (black line) was first observed at 60 days after treatment (each data
point corresponds to the mean þ SD; **p ¼ 0.0013; ***p ¼ 0.0003, Student’s t test, Welch-corrected).previous results showed that, although the subjects had
normal ciliary structure and waveform, MCC was ineffi-
cient. More recently, variants in RPGR [MIM: 300029]
have been shown to cause an X-linked PCD variant associ-
ated with ciliary disorientation,73 and a genetic variant in
STK36 [MIM: 605030] caused disorientation of cilia in an
individual with PCD.4 Here we show that ciliary disorien-
tation can occur as a direct result of a genetic lesion in
GAS2L2, and the PCD phenotype observed is due to ineffi-
cient MCC that results from improper ciliary orientation.
The proband carrying the apparent homozygous variant
in GAS2L2 (PCD-1367) has a rate of nNO production
within the normal range.63 In contrast, the proband car-
rying the compound heterozygous variant in GAS2L2
(DCP-1040) has a low rate of nNOproduction.74 The differ-
ence between nNO values could be due to the age of the
subjects, their overall health status at the time of measure-ment, and/or other genetic or environmental factors. In
healthy individuals, NO is produced constitutively within
the paranasal sinuses and in the nasal mucosa in response
to inflammation,75 but individuals with chronic rhinosi-
nusitis have a decreased rate of nNO production.76 The
biological significance of NO in the nasal region remains
unclear, but it might be essential for local host defense77
and the regulation of MCC in the respiratory tract.78 The
mechanisms involved in the reduced production of nNO
found in most PCD subjects are unknown; more studies
will need to clarify the role of ciliary function in the pro-
duction of nNO.
Until this study, no evidence of the localization, expres-
sion, or role of GAS2L2 in airway cells was available. Here
we show that the expression of GAS2L2 follows a similar
pattern to that of other cilia-specific genes.79 Although
we were able to immunoprecipitate GAS2L2 from cultured
Figure 8. Deletion of Gas2l2 Affects Mu-
cociliary Clearance in Mice
(A) Representative scintigraphy images of
real-time measurements of nasal clearance
in mice via Technetium-99. Radiolabeled
particles were delivered into the nose (left
panel). The clearance was recorded over
time (middle and right panels) with a
gamma camera.
(B) Cumulative nasal clearance in Gas2l2-
conditional-KO (n ¼ 21), controls (n ¼
20), and Dnaic1/ (n ¼ 3) treated with
TMX. In the Gas2l2-conditional-KO two
groups were observed: a groupwith normal
clearance (brown squares, n ¼ 12) and
a group with impaired clearance (red
squares, n ¼ 9).
(C) Correlation between the change in
MCC in Gas2l2-conditional-KO mice rela-
tive to controls and DV in the two groups
of Gas2l2-conditional-KO mice (r ¼
0.7151, p ¼ 0.0018).
(D) Time-lapse images of 600 frames
(5 frames/s) representing the nasopharyn-
geal clearance of fluorescence beads in con-
trol and Gas2l2-conditional-KO mice (the
scale bar represents 0.5 mm).airway cells, co-immunoprecipitation studies aimed at
identifying interacting proteins were unsuccessful (not
shown). However, using a combination of high-resolution
SIM and single-molecule GSD microscopy, we detected
GAS2L2 localizing closely with markers of basal bodies
(g-tubulin and centrin-2) and basal feet (centriolin), and
in the proximity of actin filaments and the rootlet. These
results, together with the known ability of GAS2L2 to
bind both actin andmicrotubules,25 suggest that in ciliated
cells GAS2L2 is part of the protein network at the base of
the ciliary axoneme and could providemechanical support
to the cilia during the constant physical stress of ciliary
beating. GAS2L2 could mediate the crosstalk between mi-
crotubules, actin filaments, and the proteins that consti-
tute the basal body and its appendages, thus ensuring
the proper orientation/stabilization of basal bodies and co-
ordination of the ciliary beating. In GAS2L2-deficient hu-
man cells the basal bodies were significantly less aligned
than control cells. This phenotype was recapitulated in
Gas2l2/ mTEC and in X. laevis embryos injected with
antisense Gas2l2-MO. These results suggest a conserved
role for GAS2L2 in the alignment of basal bodies. Previous
studies in X. laevis and mice showed that the docking of
basal bodies at the membrane and their relative spacing
at the apical cortex is driven by the actin cytoskeleton,15
whereas cortical microtubules are important for the align-
ment of basal bodies.15,80 In human and mTEC GAS2L2-
deficient cells, the basal bodies were normally spaced, but
their alignment was impaired. This suggests that the lack
of GAS2L2 does not disrupt the actin cytoskeleton but
might affect the stabilization of cortical MT and, subse-
quently, basal body alignment. It will be interesting to
look in detail and over time at the organization of themicrotubule network at the base of the cilium in
GAS2L2-deficient cells. In contrast, in X. laevis embryos in-
jected with antisense Gas2l2-MO targeting both Gas2l2
isoforms, we observed a decrease in both the number and
alignment of basal bodies. The severity of the phenotype
suggests that the Gas2l2 isoforms play other roles indepen-
dent of their role in cilia orientation.
Surprisingly, Gas2l2-knockout mice die neonatally. The
high lethality in Gas2l2/ mice could be associated with
developmental defects. During early embryogenesis, the
motile cilia at the embryonic node generates the right-to-
left flow required for establishing the left-right body
axis,81 resulting in the normal localization of the organs
in the body (situs solitus). We observed situs defects in
50% (3/6) of the Gas2l2/ mouse embryos dissected at
18.5 dpc, suggesting that GAS2L2 might be necessary for
proper ciliary function at the embryonic node. Another
common phenotype in mouse models of PCD is hydro-
cephalus.82 Hydrocephalic PCD mice develop enlarged
heads as a result of ventricular dilatation during
the neonatal period and die within the first month of
life.82,83 Although we observed hydrocephalus in the two
Gas2l2/ mice that survived, it is unlikely to be the pri-
mary cause of neonatal death in the Gas2l2/ mice. The
development of hydrocephalus could be related to other
genetic modifiers that play a role in the susceptibility to se-
vere PCD-associated hydrocephalus in the C57BL/6J back-
ground.82,84 Additionally, the majority of the GAS2 family
members have been implicated in controlling cell prolifer-
ation and apoptosis. For example, GAS2 is required for
proper follicular development in mice,31 GAS2L1 might
be important for the maintenance of genome stability
by controlling centriole motility and ensuring the timing
of centrosome disjunction during cell division,32 and
GAS2L3 is important for brain morphogenesis and devel-
opment.36 The fact that human and mouse GAS2L2-defi-
cient airway cells proliferate and differentiate normally in
culture suggests that GAS2L2might not play a role in regu-
lating cell proliferation or differentiation. However, in the
Gas2l2/ mice, GAS2L2 might be important for maintain-
ing homeostasis in the tissues in which it is expressed.
These phenotypes of the Gas2l2/ mice—neonatal death,
situs abnormalities, and hydrocephalus—require further
investigation.
The conditional deletion of Gas2l2 in vivo caused the
typical mouse PCD phenotype: impaired MCC accompa-
nied by mucus accumulation in the nasal cavity and re-
modeling of the nasal cavity. In Gas2l2-conditional-KO
mice we observed significantly impaired clearance direc-
tionality in the nasopharynx and a significant correlation
between impaired MCC and nasal remodeling. We
observed that 20% of the conditional-KO mice included
in the study had normal MCC, no change in nasal air
space, and no mucus accumulation, most likely because
the tamoxifen treatment was insufficient to completely
delete Gas2l2. This possibility is supported by data
showing expression of Gas2l2 in tamoxifen-treated mice.
Alternatively, in the unaffected mice the deletion of
Gas2l2 could require more time to show its effect. The
tamoxifen treatment started when the mice were 4 weeks
old; thus, the animals possessed a full complement of
properly orientated cilia. Although previous studies have
suggested that ciliated cells and ciliary proteins are very
stable,64,85 the turnover of ciliated cells and ciliary proteins
in vivo is unknown. Our results suggest that over time all
mice lacking Gas2l2 will develop PCD.
In summary, we propose that GAS2L2 plays a critical role
in the airways by inter-connecting cytoskeletal elements,
basal bodies, and basal feet. Thus, GAS2L2 helps to main-
tain the correct orientation of basal bodies in ciliated cells.
Our results demonstrate that the proper orientation of the
cilia is crucial for ensuring effective MCC and that patho-
genic variants in GAS2L2 result in poorly aligned cilia, a
hyperkinetic ciliary beat, and PCD.Accession Numbers
c.867_*343þ1207del p.? has been deposited in LOVD:
0000439768.Supplemental Data
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9. Höben, I.M., Hjeij, R., Olbrich, H., Dougherty, G.W., Nöthe-
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83. Ibañez-Tallon, I., Gorokhova, S., and Heintz, N. (2002). Loss
of function of axonemal dynein Mdnah5 causes primary
ciliary dyskinesia and hydrocephalus. Hum. Mol. Genet. 11,
715–721.
84. Finn, R., Evans, C.C., and Lee, L. (2014). Strain-dependent
brain defects in mouse models of primary ciliary dyskinesia
with mutations in Pcdp1 and Spef2. Neuroscience 277,
552–567.
85. Leigh, M.W., Carson, J.L., Gambling, T.M., and Boat, T.F.
(1992). Loss of cilia and altered phenotypic expression of
ciliated cells after acute sulfur dioxide exposure. Chest 101
(3, Suppl), 16S.
